Starlight Cardiovascular

Starlight Cardiovascular is a preclinical-stage medical technology company developing a series of devices to address pediatric congenital heart disease. Starlight Cardiovascular is creating a range of minimally invasive devices to meet the heterogeneous clinical needs of pediatric CHD. Its first product, the arterial duct stent, replaces life-saving open-chest surgery with a microcatheter-based procedure performed through a small incision in the skin. "This is an amazing development for congenital heart disease. This stent will help eliminate open-heart surgery in newborns, add a level of safety to our infant surgeries, and bring the needed technology to more catheterization labs and patients."